首页> 美国卫生研究院文献>other >Meta-Analysis of Dexmedetomidine on Emergence Agitation and Recovery Profiles in Children after Sevoflurane Anesthesia: Different Administration and Different Dosage
【2h】

Meta-Analysis of Dexmedetomidine on Emergence Agitation and Recovery Profiles in Children after Sevoflurane Anesthesia: Different Administration and Different Dosage

机译:右美托咪定对七氟醚麻醉后儿童突发性躁动和恢复特征的荟萃分析:不同的给药方式和剂量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this article is to evaluate the effect of dexmedetomidine on emergence agitation (EA) and recovery profiles in children after sevoflurane anesthesia and its pharmacological mechanisms. Standard bibliographic databases, including MEDLINE, EMBASE, PsycINFP, Springer and ISI Web of Knowledge, were artificially searched to identify all randomized controlled trials (RCTs) comparing the impact of dexmedetomidine with placebo, fentanyl and midazolam on EA and recovery profiles after sevoflurane anesthesia in post-anesthesia care unit (PACU). Two authors assessed the quality of each study independently in accordance with strict inclusion criteria and extracted data. RevMan 5.0 software was applied for performing statistic analysis. The outcomes analyzed included: 1) incidence of EA, 2) emergence time, 3) time to extubation, 4) incidence of post-operation nausea and vomiting, 5) number of patients requiring an analgesic, and 6) time to discharge from PACU. A total of 1364 patients (696 in the dexmedetomidine group and 668 in the placebo, fentanyl and midazolam group) from 20 prospective RCTs were included in the meta-analysis. Compared with placebo, dexmedetomidine decreased the incidence of EA (risk ratio [RR] 0.37; 95% CI 0.30 to 0.46), incidence of nausea and vomiting (RR 0.57; 95% CI 0.38 to 0.85) and number of patients requiring an analgesic (RR 0.43; 95% CI 0.31 to 0.59). However, dexmedetomidine had a significantly delayed effect on the emergence time (weighted mean differences [WMD] 1.16; 95% CI 0.72 to 1.60), time to extubation (WMD 0.61; 95% CI 0.27 to 0.95), and time to discharge from recovery room (WMD 2.67; 95% CI 0.95 to 4.39). Compared with fentanyl (RR 1.39; 95% CI 0.78 to 2.48) and midazolam (RR 1.12; 95% CI 0.54 to 2.35), dexmedetomidine has no significantly difference on the incidence of EA. However, the analgesia effect of dexmedetomidine on postoperation pain has no significantly statistical differences compared with fentanyl (RR 1.12; 95% CI 0.66 to 1.91), which implied that its analgesia effect might play an important role in decreasing the incident of EA. No evidence of publication bias was observed.
机译:本文的目的是评估右美托咪定对七氟醚麻醉后儿童出现躁动(EA)和恢复曲线的影响及其药理机制。人工搜索标准书目数据库,包括MEDLINE,EMBASE,PsycINFP,Springer和ISI Web of Knowledge,以鉴定所有比较右美托咪定与安慰剂,芬太尼和咪达唑仑对七氟醚麻醉后EA的影响和恢复特征的所有随机对照试验(RCT)。麻醉后护理单位(PACU)。两位作者根据严格的纳入标准独立评估了每项研究的质量并提取了数据。 RevMan 5.0软件用于执行统计分析。分析的结果包括:1)EA的发生率,2)出现时间,3)拔管时间,4)手术后恶心和呕吐的发生率,5)需要镇痛药的患者数量,6)退出PACU的时间。荟萃分析纳入了来自20个前瞻性随机对照试验的1364例患者(右美托咪定组696例,安慰剂,芬太尼和咪达唑仑组668例)。与安慰剂相比,右美托咪定降低了EA的发生率(风险比[RR] 0.37; 95%CI 0.30至0.46),恶心和呕吐的发生率(RR 0.57; 95%CI 0.38至0.85)和需要使用镇痛药的患者数量( RR 0.43; 95%CI 0.31至0.59)。然而,右美托咪定对出苗时间(加权平均差异[WMD] 1.16; 95%CI 0.72至1.60),拔管时间(WMD 0.61; 95%CI 0.27至0.95)和恢复时间有显着延迟的影响。室(WMD 2.67; 95%CI 0.95至4.39)。与芬太尼(RR 1.39; 95%CI 0.78至2.48)和咪达唑仑(RR 1.12; 95%CI 0.54至2.35)相比,右美托咪定对EA的发生率无显着差异。但是,右美托咪定对术后疼痛的镇痛作用与芬太尼相比无显着统计学差异(RR 1.12; 95%CI 0.66至1.91),这表明其镇痛作用可能在减少EA发生率中起重要作用。没有观察到发表偏见的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号